Literature DB >> 7121161

Cellular DNA amounts of squamous cell carcinomas of the head and neck region in relation to prognosis.

L E Holm.   

Abstract

Cytophotometric measurements of Feulgen DNA content were made in individual tumor cells from 45 patients with squamous cell carcinomas of the head and neck region. Eleven carcinomas were found to have a predominantly diploid distribution of DNA values, while the remaining 34 carcinomas were non-diploid. In 11 of the tumors--not entirely identical with the diploid tumors--50% or less of the malignant cells had DNA values exceeding the modal diploid value (DNA G1 + 2 S.D.), whereas 34 had higher DNA values. The non-diploid carcinomas and those where greater than 50% of the cells had DNA values greater than DNA G1 + 2 S.D. showed more advanced clinical stage, due to the presence of regional metastases. They were also associated with a poorer prognosis than the diploid carcinomas or those with less than or equal to 50% of the cells with DNA values greater than DNA G1 + 2 S.D. Cellular DNA amounts seemed to be of greater prognostic value than type of ploidy. The study indicates that DNA analysis may contribute important information of the biological behavior and prognosis of squamous cell carcinomas of the head and neck region.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7121161

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  10 in total

1.  DNA-flow cytometry of head and neck carcinoma: the importance of uniform tissue sampling and tumor sites.

Authors:  H A Westerbeek; W J Mooi; C Begg; M Dessing; A J Balm
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

2.  Nucleolar organizer regions in glottic carcinomas: comparison of DNA cytofluorometry and clinicopathological analysis.

Authors:  Y Yamamoto; T Itoh; T Saka; A Sakakura; H Takahashi
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

3.  Prognostic value of telomerase and DNA ploidy in laryngeal carcinoma.

Authors:  Talaat El Samny; Hisham El Halaby; Lobna El Fiky; Mohamed Nassar; Ali El Makhzangy; Sannaa Eissa
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-03-01       Impact factor: 2.503

4.  DNA index, cellular proliferative activity and nucleolar organizer regions in cancers of the larynx.

Authors:  J Cappiello; P Nicolai; A R Antonelli; F Facchetti; M Cadei; A Cornacchiari; P G Grigolato
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

5.  Preliminary findings of chromosomal alterations and expression of cell cycle genes in head an neck tumors.

Authors:  T Nakashima; A Masuda; T Sekiguchi; T Nishimoto; T Uemura
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

6.  Early detection in head and neck cancer - current state and future perspectives.

Authors:  Andreas O H Gerstner
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2010-10-07

7.  Cellular DNA content and prognosis in surgically treated squamous carcinoma of the larynx.

Authors:  L D Cooke; T G Cooke; G Forster; T R Helliwell; P M Stell
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

8.  Ploidy as a prognostic indicator in end stage squamous cell carcinoma of the head and neck region treated with cisplatinum.

Authors:  L D Cooke; T G Cooke; F Bootz; G Forster; T R Helliwell; D Spiller; P M Stell
Journal:  Br J Cancer       Date:  1990-05       Impact factor: 7.640

9.  Tumour growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry.

Authors:  G Forster; T G Cooke; L D Cooke; P D Stanton; G Bowie; P M Stell
Journal:  Br J Cancer       Date:  1992-05       Impact factor: 7.640

10.  DNA content, malignancy grading and prognosis in T1 and T2 oral cavity carcinomas.

Authors:  M Tytor; G Franzén; J Olofsson; U Brunk; B Nordenskjöld
Journal:  Br J Cancer       Date:  1987-11       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.